Okla. Admin. Code § 317:1-3-3.1

Current through Vol. 42, No. 8, January 2, 2025

Section 317:1-3-3.1 - Drug Utilization Review Board

(a) The Oklahoma SoonerCare Drug Utilization Review (DUR) Board shall be responsible for advising the Chief Executive Officer (hereinafter referred to as the CEO) of the Oklahoma Health Care Authority on retrospective and prospective drug utilization programs and review of pharmacy benefit issues including clinical guideline applications.

(b) The DUR Board Members shall be appointed, and may be reappointed, by the CEO as provided by law.

Added at 12 Ok Reg 1081, eff 4-3-95 (emergency); Added at 12 Ok Reg 3099, eff 7-27-95; Amended at 13 Ok Reg 1197, eff 8-1-95 (emergency); Amended at 13 Ok Reg 1621, eff 5-27-96; Amended at 27 Ok Reg 284, eff 11-3-09 (emergency); Amended at 27 Ok Reg 916, eff 5-13-10